Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1231929-97-7
Purity
95%
Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 and 6 that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. Abemaciclib is used to treat HR+ HER2- advanced or metastatic breast cancer.
Properties
Name
Abemaciclib
Smiles
CCN1CCN(CC=2C=CC(NC=3N=CC(F)=C(N3)C=4C=C(F)C=5N=C(C)N(C(C)C)C5C4)=NC2)CC1
Targets
Please log in to see this information
SDS
LY2835219 | abemacicilib | abemaciclib | bemaciclib | verzenio
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$57
2 mg
$62
5 mg
$67
10 mg
$85
15 mg
$93
20 mg
$101
25 mg
$113
30 mg
$121
35 mg
$130
40 mg
$146
45 mg
$156
50 mg
$169
75 mg
$240
100 mg
$285
Quantity
1
Total amount
$ 67
LY2835219 | abemacicilib | abemaciclib | bemaciclib | verzenio
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1231930-82-7
0